Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model

By Uchida N.   Takeda Y.   Hojo K.   Maekawa R.   Sugita K.   Yoshioka T.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1796-1801

Elsevier

Access to resources Recommend Favorite

The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts

By Breistol K.   Hendriks H.R.   Berger D.P.   Langdon S.P.   Fiebig H.H.   Fodstad O.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1602-1606

Elsevier

Access to resources Recommend Favorite

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

By Boven E.   Verschraagen M.   Hulscher T.M.   Erkelens C.A.M.   Hausheer F.H.   Pinedo H.M.   van der Vijgh W.J.F.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1148-1156

Elsevier

Access to resources Recommend Favorite

The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 3, 2012-03 ,pp. : 177-181

Bentham Science Publishers

Access to resources Recommend Favorite

The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin

By Servidei T.   Ferlini C.   Riccardi A.   Meco D.   Scambia G.   Segni G.   Manzotti C.   Riccardi R.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 930-938

Elsevier

Access to resources Recommend Favorite